Hospital-Acquired Infection (HAI) Diagnostic Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Hospital-Acquired Infection (HAI) Diagnostic in Global, including the following market information:
Global Hospital-Acquired Infection (HAI) Diagnostic Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hospital-Acquired Infection (HAI) Diagnostic market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital-Acquired Infection (HAI) Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-Acquired Infection (HAI) Diagnostic Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, By Type, 2020 (%)
China Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, By Application, 2020 (%)
Global Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Total Hospital-Acquired Infection (HAI) Diagnostic Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hospital-Acquired Infection (HAI) Diagnostic Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Global Hospital-Acquired Infection (HAI) Diagnostic Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hospital-Acquired Infection (HAI) Diagnostic market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital-Acquired Infection (HAI) Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-Acquired Infection (HAI) Diagnostic Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, By Type, 2020 (%)
- Molecular Diagnostics
- Blood Tests
- Urinalysis
China Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, By Application, 2020 (%)
- Urinary Tract Infections
- Pneumonia
- Surgical Site Infections
- Bloodstream Infections
- Other Hospital Infections
Global Hospital-Acquired Infection (HAI) Diagnostic Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Total Hospital-Acquired Infection (HAI) Diagnostic Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hospital-Acquired Infection (HAI) Diagnostic Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
- bioM?rieux
- Abbott Laboratories
- Alere, Inc.
- Roche
- Siemens Healthcare
- Becton Dickenson
- Cepheid Inc.
- Thermo Fisher Scientific
- Seegene, Inc.
- Qiagen
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Hospital-Acquired Infection (HAI) Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Infection (HAI) Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HOSPITAL-ACQUIRED INFECTION (HAI) DIAGNOSTIC OVERALL MARKET SIZE
2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size: 2021 VS 2027
2.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
3.2 Top Global Hospital-Acquired Infection (HAI) Diagnostic Companies Ranked by Revenue
3.3 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Infection (HAI) Diagnostic Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Infection (HAI) Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Markets, 2021 & 2027
4.1.2 Molecular Diagnostics
4.1.3 Blood Tests
4.1.4 Urinalysis
4.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
4.2.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
4.2.3 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2027
5.1.2 Urinary Tract Infections
5.1.3 Pneumonia
5.1.4 Surgical Site Infections
5.1.5 Bloodstream Infections
5.1.6 Other Hospital Infections
5.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
5.2.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
5.2.3 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2027
6.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
6.2.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
6.2.3 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.3.2 US Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.3.3 Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.3.4 Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.4.2 Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.3 France Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.4 U.K. Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.5 Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.6 Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.7 Nordic Countries Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.8 Benelux Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.5.2 China Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.3 Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.4 South Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.5 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.6 India Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.6.2 Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.6.3 Argentina Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.7.2 Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7.3 Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7.4 Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7.5 UAE Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 bioM?rieux
7.1.1 bioM?rieux Corporate Summary
7.1.2 bioM?rieux Business Overview
7.1.3 bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.1.4 bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.1.5 bioM?rieux Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.2.4 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.2.5 Abbott Laboratories Key News
7.3 Alere, Inc.
7.3.1 Alere, Inc. Corporate Summary
7.3.2 Alere, Inc. Business Overview
7.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.3.4 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.3.5 Alere, Inc. Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.4.4 Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.4.5 Roche Key News
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Corporate Summary
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.5.4 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.5.5 Siemens Healthcare Key News
7.6 Becton Dickenson
7.6.1 Becton Dickenson Corporate Summary
7.6.2 Becton Dickenson Business Overview
7.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.6.4 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.6.5 Becton Dickenson Key News
7.7 Cepheid Inc.
7.7.1 Cepheid Inc. Corporate Summary
7.7.2 Cepheid Inc. Business Overview
7.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.4.4 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.7.5 Cepheid Inc. Key News
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporate Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.8.4 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.8.5 Thermo Fisher Scientific Key News
7.9 Seegene, Inc.
7.9.1 Seegene, Inc. Corporate Summary
7.9.2 Seegene, Inc. Business Overview
7.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.9.4 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.9.5 Seegene, Inc. Key News
7.10 Qiagen
7.10.1 Qiagen Corporate Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.10.4 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.10.5 Qiagen Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Hospital-Acquired Infection (HAI) Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-Acquired Infection (HAI) Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HOSPITAL-ACQUIRED INFECTION (HAI) DIAGNOSTIC OVERALL MARKET SIZE
2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size: 2021 VS 2027
2.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
3.2 Top Global Hospital-Acquired Infection (HAI) Diagnostic Companies Ranked by Revenue
3.3 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 Hospital-Acquired Infection (HAI) Diagnostic Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 Hospital-Acquired Infection (HAI) Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Markets, 2021 & 2027
4.1.2 Molecular Diagnostics
4.1.3 Blood Tests
4.1.4 Urinalysis
4.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
4.2.1 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
4.2.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
4.2.3 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2027
5.1.2 Urinary Tract Infections
5.1.3 Pneumonia
5.1.4 Surgical Site Infections
5.1.5 Bloodstream Infections
5.1.6 Other Hospital Infections
5.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
5.2.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
5.2.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
5.2.3 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2027
6.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
6.2.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
6.2.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
6.2.3 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.3.2 US Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.3.3 Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.3.4 Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.4.2 Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.3 France Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.4 U.K. Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.5 Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.6 Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.7 Nordic Countries Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.4.8 Benelux Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.5.2 China Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.3 Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.4 South Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.5 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.5.6 India Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.6.2 Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.6.3 Argentina Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
6.7.2 Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7.3 Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7.4 Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
6.7.5 UAE Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
7 PLAYERS PROFILES
7.1 bioM?rieux
7.1.1 bioM?rieux Corporate Summary
7.1.2 bioM?rieux Business Overview
7.1.3 bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.1.4 bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.1.5 bioM?rieux Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.2.4 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.2.5 Abbott Laboratories Key News
7.3 Alere, Inc.
7.3.1 Alere, Inc. Corporate Summary
7.3.2 Alere, Inc. Business Overview
7.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.3.4 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.3.5 Alere, Inc. Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.4.4 Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.4.5 Roche Key News
7.5 Siemens Healthcare
7.5.1 Siemens Healthcare Corporate Summary
7.5.2 Siemens Healthcare Business Overview
7.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.5.4 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.5.5 Siemens Healthcare Key News
7.6 Becton Dickenson
7.6.1 Becton Dickenson Corporate Summary
7.6.2 Becton Dickenson Business Overview
7.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.6.4 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.6.5 Becton Dickenson Key News
7.7 Cepheid Inc.
7.7.1 Cepheid Inc. Corporate Summary
7.7.2 Cepheid Inc. Business Overview
7.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.4.4 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.7.5 Cepheid Inc. Key News
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Corporate Summary
7.8.2 Thermo Fisher Scientific Business Overview
7.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.8.4 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.8.5 Thermo Fisher Scientific Key News
7.9 Seegene, Inc.
7.9.1 Seegene, Inc. Corporate Summary
7.9.2 Seegene, Inc. Business Overview
7.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.9.4 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.9.5 Seegene, Inc. Key News
7.10 Qiagen
7.10.1 Qiagen Corporate Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
7.10.4 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
7.10.5 Qiagen Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Hospital-Acquired Infection (HAI) Diagnostic Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Infection (HAI) Diagnostic Market Drivers in Global Market
Table 3. Hospital-Acquired Infection (HAI) Diagnostic Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Infection (HAI) Diagnostic in Global Market
Table 5. Top Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Infection (HAI) Diagnostic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 30. bioM?rieux Corporate Summary
Table 31. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 32. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 35. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 36. Alere, Inc. Corporate Summary
Table 37. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 38. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 39. Roche Corporate Summary
Table 40. Roche Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 41. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 42. Siemens Healthcare Corporate Summary
Table 43. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 44. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 45. Becton Dickenson Corporate Summary
Table 46. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 47. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 48. Cepheid Inc. Corporate Summary
Table 49. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 50. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 51. Thermo Fisher Scientific Corporate Summary
Table 52. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 53. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 54. Seegene, Inc. Corporate Summary
Table 55. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 56. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 59. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 1. Hospital-Acquired Infection (HAI) Diagnostic Market Opportunities & Trends in Global Market
Table 2. Hospital-Acquired Infection (HAI) Diagnostic Market Drivers in Global Market
Table 3. Hospital-Acquired Infection (HAI) Diagnostic Market Restraints in Global Market
Table 4. Key Players of Hospital-Acquired Infection (HAI) Diagnostic in Global Market
Table 5. Top Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Share by Companies, 2016-2021
Table 8. Global Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type
Table 9. List of Global Tier 1 Hospital-Acquired Infection (HAI) Diagnostic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2022-2027
Table 30. bioM?rieux Corporate Summary
Table 31. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 32. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 35. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 36. Alere, Inc. Corporate Summary
Table 37. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 38. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 39. Roche Corporate Summary
Table 40. Roche Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 41. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 42. Siemens Healthcare Corporate Summary
Table 43. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 44. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 45. Becton Dickenson Corporate Summary
Table 46. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 47. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 48. Cepheid Inc. Corporate Summary
Table 49. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 50. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 51. Thermo Fisher Scientific Corporate Summary
Table 52. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 53. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 54. Seegene, Inc. Corporate Summary
Table 55. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 56. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
Table 57. Qiagen Corporate Summary
Table 58. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Product Offerings
Table 59. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue (US$, Mn), (2016-2021)
LIST OF FIGURES
Figure 1. Hospital-Acquired Infection (HAI) Diagnostic Segment by Type
Figure 2. Hospital-Acquired Infection (HAI) Diagnostic Segment by Application
Figure 3. Global Hospital-Acquired Infection (HAI) Diagnostic Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2020
Figure 8. By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 12. US Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 16. Germany Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 17. France Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 24. China Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 28. India Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 30. Brazil Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 33. Turkey Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 37. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 1. Hospital-Acquired Infection (HAI) Diagnostic Segment by Type
Figure 2. Hospital-Acquired Infection (HAI) Diagnostic Segment by Application
Figure 3. Global Hospital-Acquired Infection (HAI) Diagnostic Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hospital-Acquired Infection (HAI) Diagnostic Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-Acquired Infection (HAI) Diagnostic Revenue in 2020
Figure 8. By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 9. By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 10. By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 11. By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 12. US Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 16. Germany Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 17. France Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 24. China Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 28. India Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 30. Brazil Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
Figure 33. Turkey Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Hospital-Acquired Infection (HAI) Diagnostic Revenue, (US$, Mn), 2016-2027
Figure 37. bioM?rieux Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
